Skip to main navigation Skip to search Skip to main content

Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop: Digestive Diseases

  • P. Kahrilas
  • , F. Anastasiou
  • , A.J. Bredenoord
  • , H.B. El Serag
  • , J. Labenz
  • , J. Mendive
  • , E.V. Savarino
  • , D. Sifrim
  • , M. Udrescu
  • , R. Yadlapati
  • , A.P. Hungin

Research output: Contribution to journalReview articleAcademicpeer-review

8 Downloads (Pure)

Abstract

Background: Despite deprescribing initiatives to curb overutilization of proton pump inhibitors (PPIs), achieving meaningful reductions in PPI use is proving a challenge. Summary: An international group of primary care doctors and gastroenterologists examined the literature surrounding PPI use and use-reduction to clarify: (i) what constitutes rational PPI prescribing; (ii) when and in whom PPI use-reduction should be attempted; and (iii) what strategies to use when attempting PPI use-reduction. Key Messages: Before starting a PPI for reflux-like symptoms, patients should be educated on potential causes and alternative approaches including dietary and lifestyle modification, weight loss, and relaxation strategies. When commencing a PPI, patients should understand the reason for treatment, planned duration, and review date. PPI use at hospital discharge should not be continued without a recognized indication for long-term treatment. Long-term PPI therapy should be reviewed at least annually. PPI use-reduction should be based on the lack of a rational indication for long-term PPI use, not concern for PPI-associated adverse events. PPI use-reduction strategies involving switching to on-demand PPI or dose tapering, with rescue therapy for rebound symptoms, are more likely to succeed than abrupt cessation. © 2024 The Author(s). Published by S. Karger AG, Basel.
Original languageEnglish
Pages (from-to)211-220
Number of pages10
JournalDig. Dis.
Volume42
Issue number3
DOIs
Publication statusPublished - 2024

Keywords

  • Gastroesophageal reflux disease
  • Oesophagus
  • Proton pump inhibitors
  • Gastroesophageal Reflux
  • Humans
  • Proton Pump Inhibitors
  • nonsteroid antiinflammatory agent
  • proton pump inhibitor
  • anesthesia
  • Barrett esophagus
  • body weight loss
  • duodenum ulcer
  • dyspepsia
  • esophagitis
  • esophagus
  • follow up
  • gastroenterologist
  • gastroesophageal reflux
  • heartburn
  • Helicobacter infection
  • Helicobacter pylori
  • human
  • intensive care unit
  • leisure
  • lifestyle modification
  • pharmacist
  • polypharmacy
  • prescription
  • prevalence
  • primary medical care
  • randomized controlled trial (topic)
  • Review
  • risk factor
  • treatment duration
  • workshop
  • Zollinger Ellison syndrome
  • drug therapy

Fingerprint

Dive into the research topics of 'Proton Pump Inhibitors: Rational Use and Use-Reduction - The Windsor Workshop: Digestive Diseases'. Together they form a unique fingerprint.

Cite this